Peptide-mediated cell delivery: Application in protein target validation

Current Opinion in Pharmacology

Volumn 2, Issue 5, 2002, Pages 587-594

  Lindsay, Mark A ^a  

^a ASTRAZENECA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; ARGININE; BREFELDIN A; CATALASE; CHLOROQUINE; COLCHICINE; CYCLIN DEPENDENT KINASE; CYTOCHALASIN D; CYTOKINE; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR; GALANIN DERIVATIVE; HEPARIN DERIVATIVE; HOMEODOMAIN PROTEIN; MASTOPARAN; MITOGEN ACTIVATED PROTEIN KINASE; NOCODAZOLE; PACLITAXEL; PEPTIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN C JUN; PROTEIN KINASE; ROTENONE; SODIUM AZIDE; SOMATOMEDIN; SUPEROXIDE DISMUTASE; TATA BINDING PROTEIN; UNINDEXED DRUG; VASCULOTROPIN; VIRUS VECTOR; WORTMANNIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONJUGATION; CONTROLLED STUDY; DROSOPHILA; GENE DELIVERY SYSTEM; GENE TRANSLOCATION; IN VITRO STUDY; IN VIVO STUDY; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN TARGETING; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE; VIRAL GENE DELIVERY SYSTEM;

EID: 0036792527     PISSN: 14714892     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4892(02)00199-6     Document Type: Review

References (73)

1. Schwarze SR, Dowdy SF: In vivo protein transduction: intracellular delivery of biologically active proteins, compounds and DNA. Trends Pharmacol Sci 2000, 21:45-48.
2. Lindgren M, Hallbrink M, Prochiantz A, Langel U: Cell-penetrating peptides. Trends Pharmacol Sci 2000, 21:99-103.
3. Green M, Loewenstein PM: Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein. Cell 1988, 55:1179-1188.
4. Vives E, Brodin P, Lebleu B: A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J Biol Chem 1997, 272:16010-16017.
5. Derossi D, Calvet S, Trembleau A, Brunissen A, Chassaing G, Prochiantz A: Cell internalization of the third helix of the Antennapedia homeodomain is receptor-independent. J Biol Chem 1996, 271:18188-18193.
6. Lindgren M, Gallet X, Soomets U, Hallbrink M, Brakenhielm E, Pooga M, Brasseur R, Langel U: Translocation properties of novel cell penetrating transportan and penetratin analogues. Bioconjug Chem 2000, 11:619-626.
7. Joliot A, Pernelle C, Deagostini-Bazin H, Prochiantz A: Antennapedia homeobox peptide regulates neural morphogenesis. Proc Natl Acad Sci USA 1991, 88:1864-1868.
8. Pooga M, Hallbrink M, Zorko M, Langel U: Cell penetration by transportan. FASEB J 1998, 12:67-77
9. Ho A, Schwarze SR, Mermelstein SJ, Waksman G, Dowdy SF: Synthetic protein transduction domains: enhanced transduction potential in vitro and in vivo. Cancer Res 2001, 61:474-477.
10. Futaki S, Suzuki T, Ohashi W, Yagami T, Tanaka S, Ueda K, Sugiura Y: Arginine-rich peptides. An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery. J Biol Chem 2001, 276:5836-5840.
11. Wender PA, Mitchell DJ, Pattabiraman K, Pelkey ET, Steinman L, Rothbard JB: The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters. Proc Natl Acad Sci USA 2000, 97:13003-13008.
12. Suzuki T, Futaki S, Niwa M, Tanaka S, Ueda K, Sugiura Y: Possible existence of common internalization mechanisms among arginine-rich peptides. J Biol Chem 2002, 277:2437-2443.
13. Brugidou J, Legrand C, Mery J, Rabie A: The retro-inverso form of a homeobox-derived short peptide is rapidly internalised by cultured neurones: a new basis for an efficient intracellular delivery system. Biochem Biophys Res Commun 1995, 214:685-693.
14. Berlose JP, Convert O, Derossi D, Brunissen A, Chassaing G: Conformational and associative behaviours of the third helix of antennapedia homeodomain in membrane-mimetic environments. Eur J Biochem 1996, 242:372-386.
15. Hallbrink M, Floren A, Elmquist A, Pooga M, Bartfai T, Langel U: Cargo delivery kinetics of cell-penetrating peptides. Biochim Biophys Acta 2001, 1515:101-109.
16. Elmquist A, Lindgren M, Bartfai T, Langel U: VE-cadherin-derived cell-penetrating peptide, pVEC, with carrier functions. Exp Cell Res 2001, 269:237-244.
17. Dunican DJ, Doherty P: Designing cell-permeant phosphopeptides to modulate intracellular signaling pathways. Biopolymers 2001, 60:45-60.
18. Fahraeus R, Lain S, Ball KL, Lane DP: Characterization of the cyclin-dependent kinase inhibitory domain of the INK4 family as a model for a synthetic tumour suppressor molecule. Oncogene 1998, 16:587-596.
19. Hall H, Williams EJ, Moore SE, Walsh FS, Prochiantz A, Doherty P: Inhibition of FGF-stimulated phosphatidylinositol hydrolysis and neurite outgrowth by a cell-membrane permeable phosphopeptide. Curr Biol 1996, 6:580-587.
20. Kato D, Miyazawa K, Ruas M, Starborg M, Wada I, Oka T, Sakai T, Peters G, Hara E: Features of replicative senescence induced by direct addition of antennapedia-p16INK4A fusion protein to human diploid fibroblasts. FEBS Lett 1998, 427:203-208.
21. Pooga M, Kut C, Kihlmark M, Hallbrink M, Fernaeus S, Raid R, Land T, Hallberg E, Bartfai T, Langel U: Cellular translocation of proteins by transportan. FASEB J 2001, 15:1451-1453.
22. Wadia JS, Dowdy SF: Protein transduction technology. Curr Opin Biotechnol 2002, 13:52-56.
23. Kwon HY, Eum WS, Jang HW, Kang JH, Ryu J, Ryong LB, Jin LH, Park J, Choi SY: Transduction of Cu,Zn-superoxide dismutase mediated by an HIV-1 Tat protein basic domain into mammalian cells. FEBS Lett 2000, 485:163-167.
24. Jin LH, Bahn JH, Eum WS, Kwon HY, Jang SH, Han KH, Kang TC, Won MH, Kang JH, Cho SW et al.: Transduction of human catalase mediated by an HIV-1 TAT protein basic domain and arginine-rich peptides into mammalian cells. Free Radic Biol Med 2001, 31:1509-1519.
25. Silhol M, Tyagi M, Giacca M, Lebleu B, Vives E: Different mechanisms for cellular internalization of the HIV-1 Tat-derived cell penetrating peptide and recombinant proteins fused to Tat. Eur J Biochem 2002, 269:494-501.
26. Tyagi M, Rusnati M, Presta M, Giacca M: Internalization of HIV-1 tat requires cell surface heparan sulfate proteoglycans. J Biol Chem 2001, 276:3254-3261.
27. Ostenson CG, Sandberg-Nordqvist AC, Chen J, Hallbrink M, Rotin D, Langel U, Efendic S: Overexpression of protein-tyrosine phosphatase PTPσ is linked to impaired glucose-induced insulin secretion in hereditary diabetic Goto-Kakizaki rats. Biochem Biophys Res Commun 2002, 291:945-950.
28. Cutrona G, Carpaneto EM, Ulivi M, Roncella S, Landt O, Ferrarini M, Boffa LC: Effects in live cells of a c-myc anti-gene PNA linked to a nuclear localization signal. Nat Biotechnol 2000, 18:300-303.
29. Pooga M, Soomets U, Hallbrink M, Valkna A, Saar K, Rezaei K, Kahl U, Hao JX, Xu XJ, Wiesenfeld-Hallin Z et al.: Cell penetrating PNA constructs regulate galanin receptor levels and modify pain transmission in vivo. Nat Biotechnol 1998, 16:857-861.
30. Schwarze SR, Ho A, Vocero-Akbani A, Dowdy SF: In vivo protein transduction: Delivery of a biological active protein into the mouse. Science 1999, 285:1569-1572.
31. Jo D, Nashabi A, Doxsee C, Lin Q, Unutmaz D, Chen J, Ruley HE: Epigenetic regulation of gene structure and function with a cell-permeable Cre recombinase. Nat Biotechnol 2001, 19:929-933.
32. Peitz M, Pfannkuche K, Rajewsky K, Edenhofer F: Ability of the hydrophobic FGF and basic TAT peptides to promote cellular uptake of recombinant Cre recombinase: a tool for efficient genetic engineering of Mamm Genomes. Proc Natl Acad Sci USA 2002, 99:4489-4494.
33. 2- and systolic blood pressure in mice. Circ Res 2001, 89:408-414.
34. May MJ, D'Acquisto F, Madge LA, Glockner J, Pober JS, Ghosh S: Selective inhibition of NF-κB activation by a peptide that blocks the interaction of NEMO with the 1κB kinase complex. Science 2000, 289:1550-1554.
35. Stolzenberger S, Haake M, Duschl A: Specific inhibition of interleukin-4-dependent Stat6 activation by an intracellularly delivered peptide. Eur J Biochem 2001, 268:4809-4814.
36. 3-integrin represents an endogenous 'braking' mechanism during neutrophil transmatrix migration. Blood 2001, 97:3251-3258.
37. Bonny C, Oberson A, Negri S, Sauser C, Schorderet DF: Cell-permeable peptide inhibitors of JNK: novel blockers of β-cell death. Diabetes 2001, 50:77-82.
38. Kanovsky M, Raffo A, Drew L, Rosal R, Do T, Friedman FK, Rubinstein P, Visser J, Robinson R, Brandt-Rauf PW et al.: Peptides from the amino terminal mdm-2-binding domain of p53, designed from conformational analysis, are selectively cytotoxic to transformed cells. Proc Natl Acad Sci USA 2001, 98:12438-12443.
39. Schimmer AD, Hedley DW, Chow S, Pham NA, Chakrabartty A, Bouchard D, Mak TW, Trus MR, Minden MD: The BH3 domain of BAD fused to the Antennapedia peptide induces apoptosis via its alpha helical structure and independent of Bcl-2. Cell Death Differ 2001, 8:725-733.
40. Fujimoto K, Hosotani R, Miyamoto Y, Doi R, Koshiba T, Otaka A, Fujii N, Beauchamp RD, Imamura M: Inhibition of pRb phosphorylation and cell cycle progression by an antennapedia-p16(INK4A) fusion peptide in pancreatic cancer cells. Cancer Lett 2000, 159:151-158.
41. Dostmann WR, Taylor MS, Nickl CK, Brayden JE, Frank R, Tegge WJ: Highly specific, membrane-permeant peptide blockers of cGMP-dependent protein kinase I alpha inhibit NO-induced cerebral dilation. Proc Natl Acad Sci USA 2000, 97:14772-14777.
42. Riedel H, Yousaf N, Zhao Y, Dai H, Deng Y, Wang J: PSM, a mediator of PDGF-BB-, IGF-I, and insulin-stimulated mitogenesis. Oncogene 2000, 19:39-50.
43. Liu GS, Cohen MV, Mochly-Rosen D, Downey JM: Protein kinase C-ε is responsible for the protection of preconditioning in rabbit cardiomyocytes. J Mol Cell Cardiol 1999, 31:1937-1948.
44. Cussac D, Vidal M, Leprince C, Liu WQ, Cornille F, Tiraboschi G, Roques BP, Garbay C: A Sos-derived peptidimer blocks the Ras signaling pathway by binding both Grb2 SH3 domains and displays antiproliferative activity. FASEB J 1999, 13:31-38.
45. Holinger EP, Chittenden T, Lutz RJ: Bak BH3 peptides antagonize Bcl-xL function and induce apoptosis through cytochrome c-independent activation of caspases. J Biol Chem 1999, 274:13298-13304.
46. Mutoh M, Lung FD, Long YQ, Roller PP, Sikorski RS, O'Connor PM: A p21(Waf1/Cip1)carboxyl-terminal peptide exhibited cyclin-dependent kinase-inhibitory activity and cytotoxicity when introduced into human cells. Cancer Res 1999, 59:3480-3488.
47. Wang J, Dai H, Yousaf N, Moussaif M, Deng Y, Boufelliga A, Swamy OR, Leone ME, Riedel H: Grb10, a positive, stimulatory signaling adapter in platelet-derived growth factor BB-, insulin-like growth factor I-, and insulin-mediated mitogenesis. Mol Cell Biol 1999, 19:6217-6228.
48. Williams EJ, Doherty P: Evidence for and against a pivotal role of PI 3-kinase in a neuronal cell survival pathway. Mol Cell Neurosci 1999, 13:272-280.
49. Giorello L, Clerico L, Pescarolo MP, Vikhanskaya F, Salmona M, Colella G, Bruno S, Mancuso T, Bagnasco L, Russo P, Parodi S: Inhibition of cancer cell growth and c-Myc transcriptional activity by a c-Myc helix 1-type peptide fused to an internalization sequence. Cancer Res 1998, 58:3654-3659.
50. Peck D, Isacke CM: Hyaluronan-dependent cell migration can be blocked by a CD44 cytoplasmic domain peptide containing a phosphoserine at position 325. J Cell Sci 1998, 111:1595-1601.
51. Derossi D, Williams EJ, Green PJ, Dunican DJ, Doherty P: Stimulation of mitogenesis by a cell-permeable PI 3-kinase binding peptide. Biochem Biophys Res Commun 1998, 251:148-152.
52. Bonfanti M, Taverna S, Salmona M, D'Incalci M, Broggini M: p21WAF1-derived peptides linked to an internalization peptide inhibit human cancer cell growth. Cancer Res 1997, 57:1442-1446.
53. Williams EJ, Dunican DJ, Green PJ, Howell FV, Derossi D, Walsh FS, Doherty P: Selective inhibition of growth factor-stimulated mitogenesis by a cell-permeable Grb2-binding peptide. J Biol Chem 1997, 272:22349-22354.
54. Rojas M, Yao S, Lin YZ: Controlling epidermal growth factor (EGF)-stimulated Ras activation in intact cells by a cell-permeable peptide mimicking phosphorylated EGF receptor. J Biol Chem 1996, 271:27456-27461.
55. Yang Y, Ballatori N, Smith HC: Apolipoprotein B mRNA editing and the reduction in synthesis and secretion of the atherogenic risk factor, apolipoprotein B100 can be effectively targeted through TAT-mediated protein transduction. Mol Pharmacol 2002, 61:269-276.
56. Alblas J, Ulfman L, Hordijk P, Koenderman L: Activation of RhoA and ROCK are essential for detachment of migrating leukocytes. Mol Biol Cell 2001, 12:2137-2145.
57. Hall DJ, Cui J, Bates ME, Stout BA, Koenderman L, Coffer PJ, Bertics PJ: Transduction of a dominant-negative H-Ras into human eosinophils attenuates extracellular signal-regulated kinase activation and interleukin-5-mediated cell viability. Blood 2001, 98:2014-2021.
58. Hjalm G, MacLeod RJ, Kifor O, Chattopadhyay N, Brown EM: Filamin-A binds to the carboxyl-terminal tail of the calcium-sensing receptor, an interaction that participates in CaR-mediated activation of mitogen-activated protein kinase. J Biol Chem 2001, 276:34880-34887.
59. Abu-Am Y, Dowdy SF, Ross FP, Clohisy JC, Teitelbaum SL: TAT fusion proteins containing tyrosine 42-deleted IκBα arrest osteoclastogenesis. J Biol Chem 2001, 276:30499-30503
60. Embury J, Klein D, Pileggi A, Ribeiro M, Jayaraman S, Molano RD, Fraker C, Kenyon N, Ricordi C, Inverardi L, Pastori RL: Proteins linked to a protein transduction domain efficiently transduce pancreatic islets. Diabetes 2001, 50:1706-1713.
61. Ezhevsky SA, Ho A, Becker-Hapak M, Davis PK, Dowdy SF: Differential regulation of retinoblastoma tumor suppressor protein by G(1) cyclin-dependent kinase complexes in vivo. Mol Cell Biol 2001, 21:4773-4784.
62. Fujiwara T, Yamamori T, Akagawa K: Suppression of transmitter release by Tat HPC-1/syntaxin 1A fusion protein. Biochim Biophys Acta 2001, 1539:225-232.
63. 2 cytoplasmic domain. Am J Pathol 2001, 159:983-992.
64. Soga N, Namba N, McAllister S, Cornelius L, Teitelbaum SL, Dowdy SF, Kawamura J, Hruska KA: Rho family GTPases regulate VEGF-stimulated endothelial cell motility. Exp Cell Res 2001, 269:73-87.
65. Chellaiah MA, Soga N, Swanson S, McAllister S, Alvarez U, Wang D, Dowdy SF, Hruska KA: Rho-A is critical for osteoclast podosome organization, motility, and bone resorption. J Biol Chem 2000, 275:11993-12002.
66. Lissy NA, Davis PK, Irwin M, Kaelin WG, Dowdy SF: A common E2F-1 and p73 pathway mediates cell death induced by TCR activation. Nature 2000, 407:642-645.
67. Vocero-Akbani AM, Heyden NV, Lissy NA, Ratner L, Dowdy SF: Killing HIV-infected cells by transduction with an HIV protease-activated caspase-3 protein. Nat Med 1999, 5:29-33.
68. Nagahara H, Vocero-Akbani AM, Snyder EL, Ho A, Latham DG, Lissy NA, Becker-Hapak M, Ezhevsky SA, Dowdy SF: Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27Kip1 induces cell migration. Nat Med 1998, 4:1449-1452.
69. Ezhevsky SA, Nagahara H, Vocero-Akbani AM, Gius DR, Wei MC, Dowdy SF: Hypo-phosphorylation of the retinoblastoma protein (pRb) by cyclin D:Cdk4/6 complexes results in active pRb. Proc Natl Acad Sci USA 1997, 94:10699-10704.
70. Astriab-Fisher A, Sergueev DS, Fisher M, Shaw BR, Juliano RL: Antisense inhibition of P-glycoprotein expression using peptide-oligonucleotide conjugates. Biochem Pharmacol 2000, 60:83-90.
71. Mai JC, Shen H, Watkins SC, Cheng T, Robbins PD: Efficiency of protein transduction is cell type-dependent and is enhanced by dextran sulfate. J Biol Chem 2002, 277:30208-30218.
72. Koppelhus U, Awasthi SK, Zachar V, Holst HU, Ebbesen P, Nielsen PE: Cell-dependent differential cellular uptake of PNA, peptides, and PNA-peptide conjugates. Antisense Nucleic Acid Drug Dev 2002, 12:51-63.
73. Cao G, Pei W, Ge H, Liang Q, Luo Y, Sharp FR, Lu A, Ran R, Graham SH, Chen J: In vivo delivery of a Bcl-xL fusion protein containing the TAT protein transduction domain protects against ischemic brain injury and neuronal apoptosis. J Neuroscience 2002, 22:5423-5431.